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ABSTRACT
The neuronal isoform of nitric oxide synthase (nNOS) and soluble guanylate cyclase (sGC)
were localized in the cochlea, the cochlear nucleus (CN), and the superior olivary complex
(SOC) of Fisher 344 rats. In the cochlea, nNOS was identified in spiral ganglion cells by using
nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemistry and in
situ hybridization. NADPH-diaphorase staining also was detected in blood vessels of the
modiolus. By using immunohistochemistry against cyclic guanosine monophosphate, cochlear
sGC activity was localized to pericytes in the spiral ligament as well as nerve fibers
innervating outer hair cells. In the lower auditory brainstem, nNOS was localized to principal
cells of the medial nucleus of the trapezoid body (MNTB) with NADPH-diaphorase histochem-
istry and in situ hybridization. NADPH-diaphorase activity also was observed in the lateral
and medial superior olive (LSO and MSO, respectively), the superior periolivary nucleus
(SPN), the ventral and lateral nuclei of the trapezoid body (VNTB and LNTB, respectively),
and the ventral cochlear nucleus (VCN). Transcripts of the b-subunit of sGC were localized in
rat brainstem by using in situ hybridization. mRNA for sGC was expressed in neurons within
the SPN, LSO, MSO, LNTB, MNTB, VNTB, and VCN. Highest levels of sGC expression were
seen in the SPN. These results suggest that the NO/cGMP pathway is involved in both the
ascending and descending pathways of the auditory brainstem. J. Comp. Neurol. 404:52–63,
1999. r 1999 Wiley-Liss, Inc.
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Many neurotransmitters are amino acids or amino acid
derivatives stored within neuronal synaptic vesicles. On
depolarization of the neuron and subsequent calcium
influx, these bioactive molecules are released into the
synaptic cleft, where they bind to receptors that usually
are present in the postsynaptic cell membrane. Nitric
oxide (NO) is a recently discovered neurotransmitter that
also is derived from an amino acid (L-arginine) but with a
different mode of action. NO is a gas; therefore, it can
diffuse across cell membranes. NO does not act upon
plasma membrane receptors; instead, it stimulates a cyto-
solic protein, soluble guanylate cyclase (sGC), to produce
cyclic guanosine monophosphate (cGMP). Thus, the NO/
cGMP pathway is a unique neurotransmitter/neuromodu-
lator system with a role in the nervous system that is only
beginning to be understood.
In the central nervous system (CNS), the NO/cGMP
pathway has been best characterized in the cerebellum
(Garthwaite et al., 1988; Bredt and Snyder, 1989), where it
has been implicated in the induction of long-term depres-
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sion (LTD; Shibuki and Okada, 1991), a form of synaptic
plasticity. The neuronal isoform of nitric oxide synthase
(nNOS) is expressed in cerebellar granule cells as well as
basket cells of the molecular layer (Bredt et al., 1990). In
contrast, sGC is restricted to the Purkinje cells (Nakane et
al., 1983), which receive input from the nNOS-positive
granule cells. Purkinje cells also express downstream
targets of the NO/cGMP pathway, such as cGMP-depen-
dent protein kinase (cGK) and a putative cGK substrate
(Schlichter et al., 1980; Lohmann et al., 1981).
In the peripheral nervous system (PNS), nNOS is ex-
pressed in nonadrenergic, noncholinergic (NANC) nerves
(Sheng et al., 1992), which innervate the smooth muscle
lining of numerous organs, including intestine, lung, and
penis. NO produced from these nerves (Bult et al., 1990;
Sanders and Ward, 1992) activates sGC in the smooth
muscle, resulting in gut peristalsis, bronchodilation, and
penile erection (for review, see Grozdanovic et al., 1994).
In the auditory system, the NO/cGMP pathway has been
characterized in the cochlea of the guinea pig (Fessenden
et al., 1994; Zdanski et al., 1994; Fessenden and Schacht,
1997) but not in the central auditory pathways, which
process sensory information originating in the cochlea. On
acoustic stimulation, inner hair cells release glutamate,
which stimulates dendritic processes from type I spiral
ganglion neurons. The spiral ganglion cells project to the
cochlear nucleus (CN), which innervates several different
nuclei within the superior olivary complex (SOC), an
important relay station for auditory signal processing.
Both ascending pathways (eventually leading to the audi-
tory cortex, where hearing is perceived) and descending
pathways (leading back to the cochlea) are present in the
SOC (for reviews, see Helfert et al., 1991; Spangler and
Warr, 1991).
The central auditory system and the NO/cGMP pathway
both are activated by the neurotransmitter L-glutamate.
This amino acid stimulates the spiral ganglion cells as well
as neurons in the CN and the SOC (Helfert et al., 1991;
Eybalin, 1993). Glutamate also preferentially activates
nNOS, which is physically coupled to N-methyl-D-aspar-
tate (NMDA)-type glutamate receptors (Brenman et al.,
1996). NMDA receptors are expressed throughout the
neuronal auditory pathways, including the spiral ganglion
cells (Puel et al., 1991; Safieddine and Eybalin, 1992;
Kuriyama et al., 1993; Niedzielski and Wenthold, 1995),
CN (Hunter at al., 1995; Petralia et al., 1996; Sato et al.,
1998), and SOC (Sato et al., 1998). Thus, it can be
postulated that the NO/cGMP pathway is expressed in the
neuronal auditory pathways. In this study, we localized
nNOS and sGC in both central and peripheral auditory
tissues of the rat.
MATERIALS AND METHODS
Fisher 344 albino rats, 6–8 weeks old, were used in this
study. All experimental protocols on animal use were
approved by the University of Michigan Committee on Use
and Care of Animals. Animal care was under the supervi-
sion of the University of Michigan’s Unit for Laboratory
Animal Medicine in accordance with National Institutes of
Health guidelines. Except where noted, all chemicals were
purchased from Sigma Chemical Company (St. Louis,
MO).
Tissue preparation: Brainstem
Rats were anesthetized by using CO2 gas and then
decapitated. The cerebellum and brainstem were quickly
removed and frozen at 230°C. Coronal sections (15 µm)
that were obtained by using a cryostat (Bright Instrument
Co., Huntingdon, United Kingdom) were thaw-mounted
onto slides precoated with an aqueous solution of 5 mg
gelatin and 0.5 mg CrK(SO4)2/ml. Sections were stored at
280°C. Before use, sections were fixed in a solution of 4%
paraformaldehyde in phosphate-buffered saline (PBS; 10
mM Na2HPO4/NaH2PO4, 138 mM NaCl, 2.7 mM KCl, pH
7.4) for 1 hour at room temperature.
Tissue preparation: Cochlea
After decapitation, the bullae were quickly removed,
opened, and placed in 4% paraformaldehyde in PBS. The
apex of the otic capsule was opened, and fixative was
perfused through the round and oval windows. The cochlea
was incubated in fixative for 1 hour at room temperature
and then washed three times in PBS.
To obtain cochlear sections, the cochlea was decalcified
in 5% ethylenediaminetetraacetic acid (EDTA) in PBS for
2–5 days at room temperature. The tissue was then
cryoprotected by incubation in 30% sucrose in PBS over-
night at 4°C. Cochleae used for in situ hybridization were
decalcified and cryoprotected in the same solutions supple-
mented with 4% paraformaldehyde. The cochleae were
then frozen in Tissue-Tek mounting medium (Miles Inc.,
Elkhart, IN), and 15-µm sections were obtained as de-
scribed for the brainstem.
For experiments performed on surface preparations, the
otic capsule was removed, and the modiolus containing the
neurosensory epithelium was isolated. The tectorial mem-
brane and lateral wall tissues were discarded. This modio-
lar preparation was then processed for immunohistochem-
istry.
cGMP immunocytochemistry
sGC was localized by using anti-cGMP immunocytochem-
istry (de Vente et al., 1989; Fessenden and Schacht, 1997).
Briefly, rat cochleae were isolated, opened, and placed in
Hanks’balanced salt solution (HBSS; Gibco-BRL, Gaithers-
burg, MD) containing 1 mM isobutylmethylxanthine (IBMX).
The cochleae were perfused either with HBSS/IBMX alone
(control) or HBSS/IBMX supplemented with 1 mM diethyl-
amine NONOate (DEA-NO; Cayman Chemical, Ann Arbor,
MI), an NO donor. Fifteen minutes after the perfusion, the
reactions were terminated by fixation with 4% paraformal-
dehyde for 1 hour. Cochlear tissues were incubated for 1
hour at room temperature in 1 ml of blocking solution [5%
normal goat serum (Vector Laboratories; Burlingame, CA)
and 0.1% Triton X-100 in PBS]. Tissues were then incu-
bated overnight at 4°C in 100 µl of a 1:300 dilution of
anti-cGMP antibody (de Vente et al., 1989) followed by an
incubation for 1 hour at room temperature in 500 µl of a
1:200 dilution of anti-rabbit fluorescein isothiocyanate
(FITC)-conjugated secondary antibody (Vector Laborato-
ries). The neurosensory epithelium and lateral wall tis-
sues were mounted as surface preparations in Vectashield
fluorescence mounting medium (Vector Laboratories).
Immunolabeling was detected by using a Nikon fluores-
cent microscope (Tokyo, Japan). Sections were photo-
graphed by using Kodak Ektachrome 160T film (Eastman-
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Kodak, Rochester, NY) at 160 ASA. Alternatively, labeling
was detected by using a Bio-RAD 600 laser scanning
confocal unit (Bio-RAD, Richmond, CA) attached to a
Nikon Diaphot TMD inverted microscope with a 360
oil-immersion objective. Fluorescent images were pro-
cessed digitally by using Adobe Photoshop 3.0 (Adobe




Cochlear or brainstem sections were prepared as de-
scribed above. For visualization of nicotinamide adenine
dinucleotide phosphate (NADPH)-diaphorase staining, 200
µl of a solution containing 1 mM NADPH, 0.5 mM nitro
blue tetrazolium, 0.2% Triton X-100, and 50 mM Tris-HCl,
pH 8.0, was added to each slide. After a 2-hour incubation
at 37°C, slides were washed twice in PBS and mounted
with GVA mount (Zymed Laboratories, South San Fran-
cisco, CA), and the coverslips were sealed with nail polish.
Sections were photographed by using brightfield illumina-
tion.
Molecular cloning
The full-length complementary DNA (cDNA) for the
neuronal NOS isoform (GenBank accession no. X59949)
and the sGC b subunit (GenBank accession no. M22562)
from rat were kindly provided by Drs. Michael Marletta
and Michael Uhler, respectively. For nNOS, a 350-
nucleotide SstI-ApaI fragment corresponding to positions
296–646 from the rat neuronal NOS cDNA was subcloned
into pGEM -7Zf vector (Promega, Madison, WI). For sGC, a
489-nucleotide PvuII-BglII fragment corresponding to po-
sitions 131–620 from the rat sGC b subunit cDNA was
subcloned into pGEM-3Zf vector (Promega). The identity
of the subcloned cDNAs was confirmed by DNA sequenc-
ing.
Riboprobe generation
Riboprobes were synthesized from linearized templates
in a 20 µl reaction containing 1 3 transcription buffer
(Epicentre Technologies, Madison, WI), 10 mM dithiothre-
itol, 500 µM adenosine triphosphate (ATP), 500 µM cyti-
dine triphosphate (CTP), 500 µM guanosine triphosphate
(GTP), 20 U RNasin (Promega), 0.5–1.0 µg template DNA,
100 µCi 35S-uridine triphosphate (UTP), and 25 U RNA
polymerase (Epicentre Technologies). Antisense probes
were generated with T7 RNA polymerase for nNOS and
SP6 RNA polymerase for sGC. After a 2-hour incubation at
either 37°C (T7) or 42°C (SP6), reactions were terminated
with 80 µl of G50/50 buffer, which consisted of 100 mM
Tris-HCl, 12.5 mM Na4EDTA, 150 mM NaCl, and 0.2%
sodium dodecyl sulfate, pH 7.5. The reaction medium was
loaded onto a 1 ml G50 Sephadex column that had been
preequilibrated with G50/50 buffer. Eight 100 µl fractions
were collected, and peak fractions corresponding to labeled
riboprobe were quantified by scintillation counting and
stored at 280°C until use.
In situ hybridization
Fixed tissue sections were washed three times in 2 3
standard saline citrate (SSC). Next, slides were placed in
either 1 µg/ml (brain sections) or 0.1 µg/ml (cochlear
sections) proteinase K for either 10 minutes (brain) or 5
minutes (cochlea) at 37°C. Slides were washed once in
water for 2 minutes and then incubated in 100 mM
triethanolamine with 0.25% acetic anhydride, pH 8.0, for
10 minutes. Slides were washed once in 2 3 SSC for 2
minutes and then dehydrated in a stepwise series of
graded ethanol solutions (50%, 70%, 80%, 95%, 95%, 100%,
and 100% ethanol; 1.5 minutes each). Slides were left to air
dry for at least 1 hour.
Riboprobes were diluted to a concentration of between
33,000 CPM/µl and 40,000 CPM/µl by using 50% for-
mamide cocktail (Amresco, Solon, OH) supplemented with
10 mM dithiothrietol. Riboprobes were added to slides,
which were then covered with coverslips and sealed with
rubber cement. Slides were incubated with riboprobes
overnight at 55°C in a humidified chamber.
Coverslips were removed in 2 3 SSC, and the slides were
washed twice in 2 3 SSC. The sections were then incu-
bated in 10 mM Tris-HCl, 0.5 M NaCl, 200 µg/ml RNase A,
pH 8.0, for 1 hour at 37°C. Next, sections were washed for 5
minutes in 2 3 SSC, for 5 minutes in 1 3 SSC, and for 60
minutes in 0.1 3 SSC at 65°C. Sections were washed once
in 0.5 3 SSC for 5 minutes and then dehydrated as
described above. Sections were placed under autoradio-
graphic film (Eastman Kodak) for 3–5 days for preliminary
determination of labeling. Sections were then dipped in
Kodak NTB-2 autoradiographic emulsion (Eastman Ko-
dak) and exposed for 2–4 weeks in the dark. Sections were
developed in D-19 developer (Eastman Kodak) for 2 min-
utes, washed for 20 seconds in water, fixed for 3 minutes in
Rapid Fix (Eastman Kodak), and washed in water for 10
minutes. Slides were then counterstained with cresyl
violet for 2 minutes, dehydrated, and incubated in xylene
(two washes, 10 minutes each), and coverslips were
mounted by using Permount (Aldrich, Milwaukee, WI).
Slides were examined and photographed with Leitz
(Wetzlar, Germany) or Zeiss (Thornwood, NY) photomicro-
scopes under brightfield, differential interference or dark-
field illumination to visualize silver grains. Identification
of cell types was based on size, shape, and position within
regions. In the cochlear nucleus, classifications and crite-
ria developed by Cant (1991) were used.
The intensity of label with in situ hybridization was
evaluated with densitometric measurements by using the
Metamorph image-analysis system (Metamorph; Univer-
sal Images Corp., West Chester, PA). A strong signal was
defined as labeling at least 6.0 times more intense than back-
ground. A moderate signal was defined as labeling between
2.5 times and 6.0 times more intense than background.
RESULTS
Positive controls
The cerebellum was used as a positive control for in situ
hybridization experiments. The nNOS antisense probe
strongly labeled basket cells in the molecular layer and
granule cells of the granular layer (Fig. 1A), whereas the
Purkinje cells of the Purkinje cell layer were not labeled
above background. The sGC probe, on the other hand,
labeled the Purkinje cells strongly, whereas it labeled
basket cells only moderately (Fig. 1B). These findings are
consistent with previous localizations of nNOS and sGC by
in situ hybridization (Bredt et al., 1991; Matsuoka et al.,
1992; Furuyama et al., 1993). The sense probes for nNOS
and sGC did not label any cells in the cerebellum (Fig.
1C,D). Also, pretreatment of the tissue with RNase A
abolished labeling by antisense probes (data not shown).
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Cochlea
NOS was localized in the rat cochlea by using NADPH-
diaphorase histochemistry and in situ hybridization.
NADPH-diaphorase activity was detected in spiral gan-
glion cells and blood vessels within the modiolus. Nerve
fibers in Rosenthal’s canal also were stained (Fig. 2A). By
using in situ hybridization, mRNA for nNOS was detected
in spiral ganglion cells of the modiolus (Fig. 2B).
In cochlear surface preparations, sGC activity was de-
tected in pericytes lining blood vessels of the lateral wall
tissues (Fig. 3A). In the upper cochlear turns, nerve fibers
innervating outer hair cells contained sGC activity (Fig. 3B).
Lower auditory brainstem: General
NADPH-diaphorase histochemistry as well as nNOS
and sGC b mRNA expression were evaluated in the ventral
Fig.1 Cerebellar localization of mRNA for the neuronal isoform of
nitric oxide synthase (nNOS) and soluble guanylate cyclase (sGC)-b
using in situ hybridization. A: The nNOS antisense probe labeled the
granule cell layer (GL) heavily as well as basket cells (arrows) in the
molecular layer (ML). The Purkinje cell layer (PL) was unlabeled.
B: The sGC antisense probe strongly labeled the Purkinje cell layer
(arrow). Basket cells were moderately labeled (arrowhead). C,D: nNOS
(C) and sGC (D) sense probes did not label any cells in the cerebellum.
Scale bar 5 20 µm.
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cochlear nucleus (VCN) and in six regions of the SOC: the
medial, ventral, and lateral nuclei of the trapezoid body
(MNTB, VNTB, and LNTB, respectively); the medial and
lateral superior olivary nuclei (MSO and LSO, respec-
tively); and the superior periolivary nucleus (SPN). Strong
expression of mRNA for nNOS was detected in principal
cells of the MNTB (Fig. 4A) at a level of expression
comparable to that observed in cerebellar basket cells. In
contrast, expression of mRNA for the sGC b subunit in
neurons was much more widespread (Fig. 4B), a finding
consistent with previous localization of this subunit in the
brainstem (Furuyama et al., 1993).
VCN
NADPH-diaphorase activity was observed in VCN neu-
ropil (which could reflect labeling of central processes of
spiral ganglion cells) and in some, but not all, spherical
and globular bushy cells (Fig. 5A,D). Stellate multipolar
cells and octopus cells were not labeled. mRNA for nNOS
was expressed in the shell region of the VCN. Silver grains
were observed over some of the smaller shell neurons,
likely to be granule cells, based on the classification of
Hutson and Morest (1996). Spherical and globular bushy
cells and stellate multipolar cells within the VCN did not
show expression over background levels (Fig. 5B,E).
mRNA for the sGC b subunit was also seen in the VCN
(Fig. 5C), where some neurons in the shell region moder-
ately expressed this mRNA. Moderate expression of sGC b
subunit mRNA was found in most spherical and globular
bushy cells (Fig. 5F) as well as in some stellate multipolar
cells.
SOC
In the SOC, NADPH-diaphorase activity was present in
principal cells of the MNTB and in neuropil of the LSO,
SPN, and VNTB (Fig. 6A), whereas mRNA for nNOS was
detected only in the principal cells of the MNTB (Fig. 6B).
mRNA for the sGC b subunit was present in all SOC
regions, with the strongest expression seen in the SPN
(Fig. 6C).
NADPH-diaphorase activity also was present in some
cells in regions with abundant labeling of neuropil. For
example, in the LSO (Fig. 7A), a granular staining pattern
of some cells was seen in addition to neuropil labeling (Fig.
7B). This staining pattern contrasted with a more diffuse
labeling of MNTB principal cells (Fig. 7C).
Fig. 2. Localization of NOS in the cochlear modiolus by nicotin-
amide adenine dinucleotide phosphate (NADPH)-diaphorase labeling
and in situ hybridization. A: NADPH-diaphorase activity was detected
in spiral ganglion cells (arrow) and blood vessels (arrowhead). In
addition, nerve fibers in Rosenthal’s canal were stained (asterisk).
B: mRNA for nNOS was detected in spiral ganglion cells (arrow). Scale
bar 5 50 µm.
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mRNA for nNOS was found only in principal cells of the
MNTB (Fig. 8A). In contrast, mRNA for the sGC b subunit
was detected in all brainstem regions surveyed (LSO,
MSO, MNTB, VNTB, LNTB, and SPN). Examples of
labeled cells in some of these regions (Fig. 8B,D,F,H)
indicate that the strongest level of mRNA for sGC-b
expression was seen in the SPN.
DISCUSSION
Distribution of the NO/cGMP pathway
The NO/cGMP pathway is distributed widely in the
peripheral and central auditory system. NADPH-diapho-
rase activity and nNOS mRNA are colocalized in cells
activated by glutamate (spiral ganglion, MNTB), suggest-
ing that glutamate acts on the NO/cGMP pathway in these
areas. The detection of nNOS by in situ hybridization and
NADPH-diaphorase histochemistry in spiral ganglion cells
confirms and extends observations in guinea pig (Fessen-
den et al., 1994; Franz et al., 1996) and rat (Zdanski et al.,
1994). The characterization of this pathway in the auditory
brainstem is a novel contribution to our understanding of
neurotransmission and modulation in these structures.
Glutamate released from the inner hair cells activates
spiral ganglion cells, which express a variety of glutamate
receptor subtypes, including NMDA receptors (Safieddine
Fig. 3. sGC activity in rat cochlear surface preparations. A: sGC activity was evident in pericytes of
the spiral ligament (arrow). B: In the organ of Corti, sGC activity was found in nerve fibers (arrow)
crossing the tunnel of Corti (TC) to the outer hair cell region (OHC).
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and Eybalin, 1992; Kuriyama et al., 1993; Niedzielski and
Wenthold, 1995). The presence of nNOS in afferent fibers
is consistent with the established activation of this enzyme
by calcium influx through NMDA receptors. In fact, nNOS
may be associated physically with this receptor type
(Brenman et al., 1996).
Projections of spiral ganglion cells (i.e., the auditory
nerve) synapse on neurons in the cochlear nucleus. The
diffuse NADPH-diaphorase activity found in neuropil in
the VCN may be derived from such auditory nerve fibers
and terminations. In contrast, NADPH-diaphorase label-
ing of spherical and globular bushy cells often had a
granular appearance.
These cell types also contain mRNA for the b subunit of
sGC, suggesting that NO produced from NADPH diapho-
rase-positive auditory nerve terminals may activate sGC
in spherical/globular bushy cells. Because these cells project
out of the VCN, it is possible that the NO/cGMP pathway
also influences these projections to other parts of the
brainstem. The b subunit is the more conserved protein of
the two subunits of sGC and is used frequently to extrapo-
late to the localization of sGC (Matsuoka et al., 1992; Giuili
et al., 1994). It should be noted, however, that the a
subunit has a more limited distribution in some brain
regions (Furuyama et al., 1993).
In principal cells of the MNTB, again, nNOS may be
linked to NMDA receptors. MNTB principal cells preferen-
tially express the NMDA receptor subunit 2B (Saito et al.,
1998). This subunit is coupled to nNOS through the
adapter protein PSD-95 (Brenman et al., 1996). Thus,
stimulation of principal cells of the MNTB by glutamate
may lead to nNOS activation.
Fig. 4. Brainstem localization of mRNA for nNOS and sGC-b using
in situ hybridization. A: The nNOS antisense probe labeled relatively
few cell groups in the brainstem. The medial nucleus of the trapezoid
body (arrows) was labeled. B: In contrast, the sGC-b antisense probe
labeled many cells throughout the brainstem, such as the neurons of
the superior periolivary nucleus (arrow) and the medial nucleus of the
trapezoid body (arrowhead). Scale bar 5 500 µm.
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The MNTB principal cells project to other SOC regions
with large inputs to the LSO and the SPN (Helfert et al.,
1991). It is reasonable to assume that nNOS-positive fibers
from MNTB principal cells may be responsible for the
NADPH-diaphorase activity of neuropil in these regions.
The granular labeling of cells in the LSO and the SPN,
similar to the appearance in the VCN, suggests NOS-
positive nerve terminals on these cells. Because cells that
express mRNA for sGC b also were found in these areas,
the NO/cGMP pathway may be involved in connections
between MNTB principal cells and the neurons in the SPN
and the LSO. The NO/cGMP pathway may have a particu-
Fig. 5. A–F: Localization of NADPH-diaphorase activity and nNOS
and sGC-b mRNA in the ventral cochlear nucleus (VCN). A,D:
NAPDH-diaphorase activity of VCN neuropil was seen diffusely
throughout the entire VCN. In addition, some cells were labeled
(arrow in D). B,E: No labeling of neurons within the VCN was detected
with the nNOS antisense probe, as visualized by using either darkfield
(B) or brightfield (E) microscopy. C,F: Abundant labeling of neurons
within the VCN was seen with the sGC-b antisense probe (F, arrows).
Scale bars 5 100 µm in A and C (C also applies to B), 20 µm in F (also
applies to D,E).
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Fig. 6. Localization of NAPDH-diaphorase activity and nNOS and
sGC-b mRNA in the superior olivary complex. A: NADPH-diaphorase
labeling in the superior olivary complex (SOC). Principal cells in the
medial nucleus of the trapezoid body (MNTB) are labeled. In addition,
labeling of neuropil in the lateral superior olive (LSO), the superior
periolivary nucleus (SPN), and the ventral nuclei of the trapezoid body
(VNTB) is apparent. B: Distribution of mRNA for nNOS in the SOC.
Principal cells in the MNTB are labeled. C: Distribution of mRNA for
sGC in the SOC. Cells within the LSO, VNTB, SPN, and MNTB are
labeled, with strong labeling in the SPN. Scale bar 5 200 µm.
larly important role in the SPN, because mRNA for sGC b
was present in the highest amounts in this location.
The VNTB contains several different cell types, includ-
ing olivocochlear neurons that project back to the outer
hair cells of the cochlea. The VNTB contained both NADPH-
diaphorase activity and sGC-b-positive cells. Because the
efferent projections to the outer hair cells show sGC
activity, the neurons labeled by in situ hybridization in the
VNTB may include medial olivocochlear neurons. This
suggests the participation of the NO/cGMP pathway in the
descending auditory pathways.
The localization of sGC to efferent fibers in the rat
cochlea is intriguing, because, in guinea pig, sGC activity
is found in supporting cells rather than in efferent fibers
(Fessenden and Schacht, 1997). Species differences in
cochlear localization exist for a number of cell components,
including proteins involved in regulatory processes. For
example, the calcium-binding protein calretinin is present
in Deiters’ cells in guinea pig and gerbil but is absent from
these cells in rat (Dechesne et al., 1991). Similarly, calbin-
din is found in pillar cells in rat cochlea (Dechesne et al.,
1991) but not in guinea pig or gerbil (Slepecky and
Ulfendahl, 1993; Pack and Slepecky, 1995). Such differ-
ences in biochemical regulatory pathways between species
may have important consequences on cochlear function
that remain to be explored.
Differences in labeling between
NADPH-diaphorase histochemistry
and nNOS in situ hybridization
In the VCN and SOC, NADPH-diaphorase activity was
detected in some cells that did not express mRNA for
nNOS. Because all NOS isoforms exhibit NADPH-diapho-
rase activity, these cells may express a different NOS
isoform, such as endothelial NOS (which also has been
localized to neurons of the brain; Dinerman et al., 1994).
Another strong possibility is that an alternatively spliced
isoform of nNOS exists in these cells. One such isoform,
nNOS b, lacks exon 2 but retains enzymatic activity
(Brenman et al., 1996). Our nNOS riboprobe was directed
against exon 2; therefore, we would not have been able to
detect this splice variant by using in situ hybridization.
Indeed, recent experiments indicate that nNOS b is pre-
sent in the VCN (Eliasson et al., 1997), which is compatible
with the suggestion that the cellular NADPH-diaphorase
activity in this location is due to this isoform.
Functional implications for the NO/cGMP
pathway in the auditory system
Consistent with its proposed activity in other brain
regions, the NO/cGMP pathway could modulate neuro-
transmitter release in the auditory brainstem. In cultured
neurons and slices from a variety of brain areas (Hanbauer
et al., 1992; Montague et al., 1994), exogenous NO can
elicit the release of different neurotransmitters, such as
acetylcholine, dopamine, glycine, and glutamate. Because
all of these neurotransmitters are found in the auditory
brainstem, it is conceivable that the NO/cGMP pathway
could regulate their release.
In addition, NO in the central auditory pathways may
act as a feedback inhibitor of glutamate receptor activity.
For example, NO produced by activation of NMDA-type
glutamate receptors (Manzoni and Bockaert, 1993) or
supplied from exogenous NO donors (Manzoni et al., 1992;
Lipton et al., 1993) inhibit NMDA receptor activity. NO-
mediated inhibition of glutamate receptors also has been
described in the visual system (McMahon and Ponomar-
eva, 1996). Because excess glutamate can cause neurotox-
icity in the CNS, this type of inhibition of glutamate
receptors by NO itself may protect neurons from toxic
damage. In the auditory pathways, NO may inactivate
glutamate receptors during periods of excessive neuronal
activity, like what would occur during acoustic overstimu-
lation. Such a protective effect would be expected in neurons in
Fig. 7. NADPH-diaphorase labeling in the SOC. A,B: Labeling of
LSO with granular-type labeling (arrow). C: Labeling of MNTB
principal cells. NAPDH-diaphorase activity in these cells is more
diffuse (arrow). Scale bars 5 100 µm in A, 50 µm in C (also applies
to B).
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Fig. 8. Brightfield visualization of in situ hybridization labeling in
various SOC regions. In situ hybridization experiments using nNOS
(A,C,E,G) and sGC-b (B,D,F,H) antisense probes were performed on
the MNTB (A,B), SPN (C,D), VNTB (E,F), and LSO (G,H). Labeled
cells are indicated by arrows. mRNA for nNOS was detected only in
the MNTB (A), whereas mRNA for sGC was detected in all regions
(B,D,F,H). Labeling was strongest in the SPN (D). Scale bar 5 20 µm.
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which nNOS and NMDA receptors are coexpressed, such
as spiral ganglion cells and MNTB principal cells.
In summary, the NO/cGMP pathway is distributed widely
in the ascending and descending auditory pathways of the
rat. nNOS is associated largely with structures that
contain NMDA receptors, consistent with the notion that
NO is a major modulator and mediator in glutamatergic
neurons. The localization of both NOS and the NO target,
sGC, now allows for rational experimentation to test the
role(s) of this fascinating pathway in audition.
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